Stimulation protocols for Severe Endometriosis- is there any difference?

Roya Rozati, Wajeeda Tabasum, Salwa Sahar Azimi, Zinneerah Syedani, Sripriya Vennamaneni, Ayesha Fathima
In: Brazilian Journal of Development · 2024 · vol. 10(1) , pp. 282–303 · doi:10.34117/bjdv10n1-019 · W4390589172
article OA: diamond CC0 ⤵ 1 in-corpus citation
🔓 Open OA copy Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This study found that the GnRH agonist long protocol resulted in superior clinical pregnancy and live birth rates in women with endometriosis undergoing ICSI compared to the progestin-primed ovarian stimulation and combined oral contraceptive protocols.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-12 · read from full text ⓘ

This cross-sectional study (March 2019–March 2023) compared ART outcomes in 126 infertile women with endometriosis undergoing their first ICSI cycle at a single hospital in Hyderabad, India, using three pre-ICSI stimulation downregulation approaches: GnRH agonist long protocol, progestin-primed ovarian stimulation (PPOS), and combined oral contraceptives. The study reported higher clinical pregnancy rates with the GnRH agonist long protocol (57.5%) than with PPOS (34.2%) and combined OCPs (40.54%), and it also found higher clinical pregnancy and live birth rates overall with extended pituitary downregulation using GnRH agonists; segmented IVF including FET cycles likewise showed higher live birth rates in the GnRH agonist group. A major limitation is that the design is cross-sectional and protocol assignment appears not to be randomized, and outcomes are from a single center. This paper is centrally about endometriosis — it compares stimulation protocols (GnRH agonist long vs PPOS vs combined OCP) to assess differences in ICSI outcomes in women with severe endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Endometriosis, being an estrogen-dependent condition, can lead to subfertility in women. Those facing difficulty achieving pregnancy goals may need assistance from assisted reproductive technology (ART). Due to the challenges posed by endometriosis in natural conception, assisted reproductive technologies like IVF and ICSI. Objective of the study: This study aimed to compare ART outcomes in women with endometriosis following the three distinct groups of protocols undergoing various treatment modalities, namely the progestin-primed ovarian Stimulation protocol, GnRH agonist long protocol, and Combined Oral Contraceptives (OCPs). This investigation aims to enhance our understanding of how different stimulation protocols may influence ART outcomes Methodology: This is a cross-sectional study between March 2019 to March 2023. The study collected data from 126 infertile women diagnosed with endometriosis, who were undergoing their first intracytoplasmic sperm injection (ICSI) cycle at MHRT Hospital and Research Center, Hyderabad, Telangana India. Patients in each group were classified into three Protocols ie-GnRH agonist Long Protocol, Progestins primed Ovarian Stimulation, and Combined Oral Contraceptives. The outcomes of the ICSI program were evaluated Result: The findings from our study suggest that women with endometriosis undergoing ICSI experience improved reproductive outcomes when subjected to prolonged downregulation with GnRH agonist long protocol, Progestin primed Ovarian Stimulation and Combined Oral Contraceptives before initiating ovarian stimulation. Notably, the clinical pregnancy rate is notably higher at GnRH agonist long Protocol 57.5% compared to the alternative protocols: PPOS at 34.2 % and Combined Oral Contraceptives at 40.54 %. The groups subjected to extended pituitary downregulation with GnRH agonists long protocol demonstrated superior clinical pregnancy and live birth rates compared to those following the PPOS and Combined Oral Contraceptives. Our segmented IVF approach, including FET cycles, revealed a higher live birth rate in the GnRH agonist protocol compared to the PPOS and Combined Oral Contraceptives. Conclusion: This study demonstrates that GnRH agonists' long protocol demonstrated superior clinical pregnancy and live birth rates compared to those following the PPOS and Combined Oral Contraceptives. Better clinical outcomes were observed in the GnRH agonist long protocol group when compared to the PPOS and Combined Oral Contraceptive group.
Full text 13,774 characters · extracted from oa-doi-fallback · click to expand
Stimulation protocols for Severe Endometriosis- is there any difference? DOI: https://doi.org/10.34117/bjdv10n1-019Keywords: stimulation, GnRH agonist, progestin primed ovarian stimulation, combined oral contraceptivesAbstract Endometriosis, being an estrogen-dependent condition, can lead to subfertility in women. Those facing difficulty achieving pregnancy goals may need assistance from assisted reproductive technology (ART). Due to the challenges posed by endometriosis in natural conception, assisted reproductive technologies like IVF and ICSI. Objective of the study: This study aimed to compare ART outcomes in women with endometriosis following the three distinct groups of protocols undergoing various treatment modalities, namely the progestin-primed ovarian Stimulation protocol, GnRH agonist long protocol, and Combined Oral Contraceptives (OCPs). This investigation aims to enhance our understanding of how different stimulation protocols may influence ART outcomes Methodology: This is a cross-sectional study between March 2019 to March 2023. The study collected data from 126 infertile women diagnosed with endometriosis, who were undergoing their first intracytoplasmic sperm injection (ICSI) cycle at MHRT Hospital and Research Center, Hyderabad, Telangana India. Patients in each group were classified into three Protocols ie-GnRH agonist Long Protocol, Progestins primed Ovarian Stimulation, and Combined Oral Contraceptives. The outcomes of the ICSI program were evaluated Result: The findings from our study suggest that women with endometriosis undergoing ICSI experience improved reproductive outcomes when subjected to prolonged downregulation with GnRH agonist long protocol, Progestin primed Ovarian Stimulation and Combined Oral Contraceptives before initiating ovarian stimulation. Notably, the clinical pregnancy rate is notably higher at GnRH agonist long Protocol 57.5% compared to the alternative protocols: PPOS at 34.2 % and Combined Oral Contraceptives at 40.54 %. The groups subjected to extended pituitary downregulation with GnRH agonists long protocol demonstrated superior clinical pregnancy and live birth rates compared to those following the PPOS and Combined Oral Contraceptives. Our segmented IVF approach, including FET cycles, revealed a higher live birth rate in the GnRH agonist protocol compared to the PPOS and Combined Oral Contraceptives. Conclusion: This study demonstrates that GnRH agonists' long protocol demonstrated superior clinical pregnancy and live birth rates compared to those following the PPOS and Combined Oral Contraceptives. Better clinical outcomes were observed in the GnRH agonist long protocol group when compared to the PPOS and Combined Oral Contraceptive group. References Gruber, T. M., &Mechsner, S. (2021). Pathogenesis of endometriosis: the origin of pain and subfertility. Cells, 10(6), 1381. Amalinei, C., Păvăleanu, I., Lozneanu, L., Balan, R., Giuşcă, S. E., &Căruntu, I. D. (2018). Endometriosis—insights into a multifaceted entity. Folia Histochemica et Cytobiologica, 56(2), 61-82. Mahapatra, D. K., Asati, V., & Bharti, S. K. (2015). GnRH Analogs As Modulator of LH and FSH: Exploring Clinical Importance. In Mechanical and Physico-Chemical Characteristics of Modified Materials (pp. 289-337). Apple Academic Press. de Ziegler, D., Streuli, I., Marszalek, A., Gayet, V., &Chapron, C. (2013). Preparing the Endometrium to Maximize Success: The Dynamics of Artificial Cycles. Principles of Oocyte and Embryo Donation, 109-127. Cao, X., Chang, H. Y., Xu, J. Y., Zheng, Y., Xiang, Y. G., Xiao, B., ... & Mao, G. H. (2020). The effectiveness of different down-regulating protocols on in vitro fertilization-embryo transfer in endometriosis: a meta-analysis. Reproductive Biology and Endocrinology, 18(1), 1-12. Da Broi, M. G., Ferriani, R. A., & Navarro, P. A. (2019). Ethiopathogenic mechanisms of endometriosis-related infertility. JBRA Assisted Reproduction, 23(3), 273. Johnson, N. P., Hummelshoj, L., Adamson, G. D., Keckstein, J., Taylor, H. S., Abrao, M. S., ... & Giudice, L. C. (2017). World Endometriosis Society consensus on the classification of endometriosis. Human reproduction, 32(2), 315-324. Signorile, P. G., & Baldi, A. (2010). Endometriosis: new concepts in the pathogenesis. The international journal of biochemistry & cell biology, 42(6), 778-780. Harb, H. M., Gallos, I. D., Chu, J., Harb, M., & Coomarasamy, A. (2013). The effect of endometriosis on in vitro fertilisation outcome: a systematic review and meta‐analysis. BJOG: An International Journal of Obstetrics &Gynaecology, 120(11), 1308-1320. Johnson, N. P., Hummelshoj, L., World Endometriosis Society Montpellier Consortium, Abrao, M. S., Adamson, G. D., Allaire, C., ... &Vercellini, P. (2013). Consensus on current management of endometriosis. Human reproduction, 28(6), 1552-1568. Benaglia, L., Somigliana, E., Vercellini, P., Benedetti, F., Iemmello, R., Vighi, V., ... & Ragni, G. (2010). The impact of IVF procedures on endometriosis recurrence. European Journal of Obstetrics & Gynecology and Reproductive Biology, 148(1), 49-52. D'Hooghe, T. M., Debrock, S., Hill, J. A., & Meuleman, C. (2003). Endometriosis and subfertility: is the relationship resolved?. In Seminars in reproductive medicine (Vol. 21, No. 02, pp. 243-254). Copyright© 2003 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.:+ 1 (212) 584-4662. Jirge, P. R., Patil, M. M., Gutgutia, R., Shah, J., Govindarajan, M., Roy, V. S., ... & Sharara, F. I. (2022). Ovarian stimulation in assisted reproductive technology cycles for varied patient profiles: An Indian perspective. Journal of Human Reproductive Sciences, 15(2), 112. Somigliana, E., Piani, L. L., Paffoni, A., Salmeri, N., Orsi, M., Benaglia, L., ... & Vigano’, P. (2023). Endometriosis and IVF treatment outcomes: unpacking the process. Reproductive Biology and Endocrinology, 21(1), 107. Chantalat, E., Valera, M. C., Vaysse, C., Noirrit, E., Rusidze, M., Weyl, A., ... &Lenfant, F. (2020). Estrogen receptors and endometriosis. International journal of molecular sciences, 21(8), 2815. Huang, J., Xie, Q., Lin, J., Lu, X., Zhu, J., Gao, H., ... & Kuang, Y. (2019). Progestin-primed ovarian stimulation with dydrogesterone versus medroxyprogesterone acetate in women with polycystic ovarian syndrome for in vitro fertilization: a retrospective cohort study. Drug design, development and therapy, 4461-4470. van Loenen, A. C., Huirne, J. A., Schats, R., Hompes, P. G., &Lambalk, C. B. (2002). GnRH agonists, antagonists, and assisted conception. In Seminars in reproductive medicine (Vol. 20, No. 04, pp. 349-364). Copyright© 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.:+ 1 (212) 584-4662. Ruan, M., Fang, L., Yang, S., Chen, Z., Wu, Y., Qu, X., ... & Cheng, J. (2021). Prolonged pituitary downregulation with gonadotropin-releasing hormone agonist improves the live-birth rate: a retrospective cohort study comparing 3 different protocols. Ann Palliat Med. Ying, Y., Yang, T., Zhang, H., Liu, C., & Zhao, J. (2019). Prolonged pituitary down-regulation with full-dose of gonadotropin-releasing hormone agonist in different menstrual cycles: a retrospective cohort study. PeerJ, 7, e6837. Kumar, P., & Sharma, A. (2014). Gonadotropin-releasing hormone analogs: Understanding advantages and limitations. Journal of human reproductive sciences, 7(3), 170. Weisberg, E., & Fraser, I. S. (2015). Contraception and endometriosis: challenges, efficacy, and therapeutic importance. Open access journal of contraception, 105-115. Zaat, T., Zagers, M., Mol, F., Goddijn, M., van Wely, M., &Mastenbroek, S. (2021). Fresh versus frozen embryo transfers in assisted reproduction. Cochrane Database of Systematic Reviews, (2). Guan, S., Feng, Y., Huang, Y., & Huang, J. (2021). Progestin-primed ovarian stimulation protocol for patients in assisted reproductive technology: a meta-analysis of randomized controlled trials. Frontiers in endocrinology, 12, 702558. Lan, J., Wu, Y., Wu, Z., Wu, Y., Yang, R., Liu, Y., ... & Zhang, Q. (2021). Ultra-Long GnRH agonist protocol during IVF/ICSI improves pregnancy outcomes in women with adenomyosis: a retrospective cohort study. Frontiers in Endocrinology, 12, 609771. Kalafat, E., Turkgeldi, E., Yıldız, S., Dizdar, M., Keles, I., & Ata, B. (2022). Outcomes of a GnRH agonist trigger following a GnRH antagonist or flexible progestin-primed ovarian stimulation cycle. Frontiers in Endocrinology, 13, 837880. Gullo, G., Basile, G., Cucinella, G., Greco, M. E., Perino, A., Chiantera, V., & Marinelli, S. (2023). Fresh vs. frozen embryo transfer in assisted reproductive techniques: a single center retrospective cohort study and ethical-legal implications. European Review for Medical & Pharmacological Sciences, 27(14). Xiao, Z. N., Peng, J. L., Yang, J., & Xu, W. M. (2019). Flexible GnRH antagonist protocol versus progestin-primed ovarian stimulation (PPOS) protocol in patients with polycystic ovary syndrome: comparison of clinical outcomes and ovarian response. Current medical science, 39(3), 431-436. Wang, N., Zhu, Q., Ma, M., Liang, Z., Tao, Y., Wang, Y., & Kuang, Y. (2020). Comparison of a progestin-primed ovarian stimulation protocol with a flexible GnRH antagonist protocol in patients with polycystic ovary syndrome who are participating in an IVF programme: study protocol for a randomised controlled trial. BMJ open, 10(12), e038153. Zeng, C., Xu, J. N., Zhou, Y., Zhou, Y. F., Zhu, S. N., & Xue, Q. (2014). Reproductive performance after surgery for endometriosis: predictive value of the revised American Fertility Society classification and the endometriosis fertility index. Gynecologic and obstetric investigation, 77(3), 180-185. Santulli, P., Bourdon, M., Presse, M., Gayet, V., Marcellin, L., Prunet, C., ... &Chapron, C. (2016). Endometriosis-related infertility: assisted reproductive technology has no adverse impact on pain or quality-of-life scores. Fertility and Sterility, 105(4), 978-987. Vassilopoulou L, Matalliotakis M, Zervou MI, Matalliotaki C, Spandidos DA, Matalliotakis I, Goulielmos GN. Endometriosis and in vitro fertilisation. Experimental and Therapeutic Medicine. 2018 Aug 1;16(2):1043-51. Zeng, C., Lu, R., Li, X., Kuai, Y., Wang, S., & Xue, Q. (2022). The presence of ovarian endometrioma adversely affect ovarian reserve and response to stimulation but not oocyte quality or IVF/ICSI outcomes: a retrospective cohort study. Journal of Ovarian Research, 15(1), 1-12. Sanchez, A. M., Vanni, V. S., Bartiromo, L., Papaleo, E., Zilberberg, E., Candiani, M., ... &Viganò, P. (2017). Is the oocyte quality affected by endometriosis? A review of the literature. Journal of ovarian research, 10(1), 1-11. Maggi, R., Cariboni, A. M., Marelli, M. M., Moretti, R. M., Andre, V., Marzagalli, M., & Limonta, P. (2016). GnRH and GnRH receptors in the pathophysiology of the human female reproductive system. Human reproduction update, 22(3), 358-381. Luca, A., Nemescu, D., Butnaru, M., Butnariu, A., &Onofriescu, M. (2016). Ovarian stimulation outcome in infertile women with endometriosis undergoing IVF. Ginekologia Polska, 87(1), 37-41. Moreira, M. L., Vitório, L. L. M. R., Mazzarollo, A. V. S., Schiezari, B. A., de Souza, J. R., dos Santos, C. R., ... & Vilaça, R. S. (2022). Endometriose: fisiopatologia e manejoterapêutico: Endometriosis: pathophysiology and therapeutic management. Brazilian Journal of Development, 8(11), 74540-74558. Surrey, E. S. (2013, March). Endometriosis and assisted reproductive technologies: maximizing outcomes. In Seminars in reproductive medicine (Vol. 31, No. 02, pp. 154-163). Thieme Medical Publishers. Daniilidis, A., & Pados, G. (2018). Comments on the ESHRE recommendations for the treatment of minimal endometriosis in infertile women. Reproductive BioMedicine Online, 36(1), 84-87. Hamdan, M., Dunselman, G., Li, T. C., & Cheong, Y. (2015). The impact of endometrioma on IVF/ICSI outcomes: a systematic review and meta-analysis. Human reproduction update, 21(6), 809-825. Marcus, S. F., & Edwards, R. G. (1994). High rates of pregnancy after long-term down-regulation of women with severe endometriosis. American journal of obstetrics and gynecology, 171(3), 812-817. Zikopoulos, K., Kolibianakis, E. M., &Devroey, P. (2004). Ovarian stimulation for in vitro fertilization in patients with endometriosis. Acta obstetricia et gynecologica Scandinavica, 83(7), 651-655. Benaglia, L., Bermejo, A., Somigliana, E., Faulisi, S., Ragni, G., Fedele, L., & Garcia-Velasco, J. A. (2013). In vitro fertilization outcome in women with unoperated bilateral endometriomas. Fertility and sterility, 99(6), 1714-1719. Georgiou, E. X., Melo, P., Baker, P. E., Sallam, H. N., Arici, A., Garcia‐Velasco, J. A., ... &Granne, I. E. (2019). Long‐term GnRH agonist georgpy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis. Cochrane Database of Systematic Reviews, (11). Santana, D. C., Resende, M. S. D. A. B., de Almeida, L. M. G. F., Aragão, G. L. B., & Menezes, M. V. C. (2022). Efeitosterapêuticos da suplementação de Ômega 3 empacientes com Endometriose Therapeutic effects of Omega-3 supplementation in patients with Endometriosis. Brazilian Journal of Development, 8(6), 47557-47569. Surrey, E. S. (2015). Endometriosis-related infertility: the role of the assisted reproductive technologies. BioMed research international, 2015. Zareii, A., Davoodi, S., Alborzi, M., Moghadam, M. E., & Askary, E. (2021). Co-administration of GnRH agonists with vaginal progesterone compared to vaginal progesterone in luteal phase support of the frozen-thawed embryo transfer cycle: An RCT. International Journal of Reproductive BioMedicine, 19(10), 863.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (45)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK